Role of the endocannabinoid system in Alzheimer's disease:: New perspectives

被引：56

作者：

Pazos, MR ^{[1
]}

Núñez, E ^{[1
]}

Benito, C ^{[1
]}

Tolón, RM ^{[1
]}

Romero, J ^{[1
]}

机构：

[1] Fdn Hosp Alcorcon, Lab Apoyo Invest, Madrid 28922, Spain

来源：

LIFE SCIENCES | 2004年 / 75卷 / 16期

关键词：

endocannabinoids; receptors; Alzheimer's disease; inflammation; Glia;

D O I：

10.1016/j.lfs.2004.03.026

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The role of the endocannabinoid system in several diseases is currently under intense study. Among these, Alzheimer's disease may be a new promising area of research. We have recently reported the existence of profound changes in the location and density of several elements of this system in Alzheimer's disease tissue samples, indicating that a non-neuronal endocannabinoid system is up-regulated in activated glia. Additional data from other groups suggest that glial cells may be important elements in the regulation of endocannabinoid system activity, both in health as in disease. Some of these aspects are briefly discussed in the present review. (C) 2004 Elsevier Inc. All rights reserved.

引用

页码：1907 / 1915

页数：9

共 42 条

[11]

Grundy RI, 2001, MOL NEUROBIOL, V24, P29

[12]

HERKENHAM M, 1995, CANNABINOID RECEPTOR, P145

[13] Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on β-amyloid-induced toxicity in PC12 cells [J].

Iuvone, T ;

Esposito, G ;

Esposito, R ;

Santamaria, R ;

Di Rosa, M ;

Izzo, AA .

JOURNAL OF NEUROCHEMISTRY, 2004, 89 (01) :134-141

[14] Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor [J].

Klegeris, A ;

Bissonnette, CJ ;

McGeer, PL .

BRITISH JOURNAL OF PHARMACOLOGY, 2003, 139 (04) :775-786

[15]

Klein T W, 2001, Pain Res Manag, V6, P95

[16] Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type [J].

Law, A ;

Gauthier, S ;

Quirion, R .

BRAIN RESEARCH REVIEWS, 2001, 35 (01) :73-96

[17] Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo [J].

Lichtman, AH ;

Hawkins, EG ;

Griffin, G ;

Cravatt, BF .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (01) :73-79

[18]

LYNN AB, 1994, J PHARMACOL EXP THER, V268, P1612

[19] The molecular bases of Alzheimer's disease and other neurodegenerative disorders [J].

Maccioni, RB ;

Muñoz, JP ;

Barbeito, L .

ARCHIVES OF MEDICAL RESEARCH, 2001, 32 (05) :367-381

[20] CB1 cannabinoid receptors and on-demand defense against excitotoxicity [J].

Marsicano, G ;

Goodenough, S ;

Monory, K ;

Hermann, H ;

Eder, M ;

Cannich, A ;

Azad, SC ;

Cascio, MG ;

Gutiérrez, SO ;

van der Stelt, M ;

López-Rodríguez, ML ;

Casanova, E ;

Schütz, G ;

Zieglgänsberger, W ;

Di Marzo, V ;

Behl, C ;

Lutz, B .

SCIENCE, 2003, 302 (5642) :84-88

← 1 2 3 4 5 →